Clinical trial
A Multi-center, Randomized, Double-Blind, Parallel Comparative, Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin Versus Levofloxain in Treating Adult Patients With CAP
NCT02205112 is registered in ClinicalTrials.gov with TaiGen Biotechnology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-Blind, Parallel Comparative, Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin Versus Levofloxain in Treating Adult Patients With CAP
- Lead sponsor
- TaiGen Biotechnology Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- May 15, 2017
- Enrollment
- 598 (actual)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.